- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
Following the news that the US secured virtually all available short-term stock of remdesivir; Brian Hicks, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view: “The US Government’s latest purchase will have wide-ranging implications for its own citizens, as well as for the broader global community. Firstly, as six doses […]
Healthcare sector witnessed 12% decline in deal activity during week ended June 28
The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 12% during the week ended June 28, 2020 compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “Though the healthcare sector has been relatively resilient compared to other sectors amid […]
MENA oil and gas pipeline sector still reeling from impacts of weak demand and COVID-19
The Middle East and African (MENA) oil and gas pipelines sector has been impacted due to low oil prices and weak demand as a result of COVID-19. The pandemic has affected the progress of several projects, forcing operators to opt for alternative strategies such as delaying project completion or reducing capital expenditures. While these approaches […]
Adenovirus-vectored vaccines for COVID-19 could face booster issues
The usefulness of adenovirus-vectored vaccines for COVID-19 is currently questionable as these should only be administered two times over the lifetime of an individual and those currently in development only last for a year, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: “Repeated administration of adenovirus-vectored vaccines can […]
Tonix Pharmaceuticals and Southern Research COVID-19 vaccine provides a novel vector
Tonix Pharmaceuticals and Southern Research have partnered to create a COVID-19 vaccine based on Tonix’s proprietary horsepox vaccine platform. The use of the horsepox vector will be an important addition to the 234 COVID-19 vaccines currently being developed, as it will add another vector to be used for COVID-19 vaccines and boosters, along with providing […]
IVIg is available for treating COVID-19
While researchers investigate recovered patient antibody treatments for COVID-19, intravenous immunoglobulin (IVIg) is a similar type of treatment that is already available and could be used for COVID-19, says GlobalData, a leading data and analytics company. Johanna Swanson, Product Manager at GlobalData, comments: “IVIg is generated from the pooled immunoglobulin G of approximately one thousand blood […]
Less than 30% of AML cases considered to be in adverse risk group
Acute myeloid leukemia (AML), a serious haematological cancer, remains a disease often defined by poor prognosis. However, less than 30% of diagnosed incident cases of AML are considered of adverse risk, according to GlobalData, a leading data analytics company. The company’s latest report, ‘Acute Myeloid Leukemia: Epidemiology Forecast to 2029’, reveals that by 2029, there […]
Alzheimer’s disease market to reach $12.9bn in 2028 driven by launch of new pipeline agents
Drug sales for Alzheimer’s disease (AD) and mild cognitive impairment (MCI) collectively reached $2.2bn in 2018 across the eight major markets (8MM*). By the end of the forecast period in 2028, these sales are forecast to increase to $12.9bn at a compound annual growth rate (CAGR) of 19.3%, according to GlobalData, a leading data and […]
Bridge to heart transplant falls short for patients on ECMO highlighting areas of improvement
Following recent guidance from healthcare regulating agencies to increase available extracorporeal membrane oxygenation (ECMO) devices in hospitals for use as an alternative to ventilators, the newest publishing in JACC showing that ventricular assist devices (VAD) devices outperform ECMO units in bridge to heart transplants reminds manufacturers and doctors about the risk factors associated with ECMO, […]
Pharma increases sedative drug production for COVID-19 patients as FDA declare shortages
As the COVID-19 pandemic continues to sweep across the US, around 12% of intensive care hospitalized COVID-19 patients need to be placed on a ventilator. Not only does the procedure to do this require thousands of patients to be sedated, but they must also remain sedated if they have to stay on a ventilator longer-term. This […]
ALS Global Day reiterates the need for an elusive cure despite promising late-stage pipeline
The International Alliance of Amyotrophic Lateral Sclerosis (ALS)/ Motor Neuron Disease (MND) Associations, recognizes June 21 as the ALS Global Day. The goal of this yearly campaign is to promote global awareness and raise funds for ALS research activities. Sarah Elsayed, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on […]
Acute myeloid leukemia market to reach $5.1bn by 2029 driven by novel agents and label expansions
The acute myeloid leukemia (AML) market is expected to grow from $1.4bn in 2019 to $5.1bn in 2029 across the eight major markets (8MM*) at a high compound annual growth rate (CAGR) of 13.6%, according to GlobalData, a leading data and analytics company. This growth will be driven by label expansions of the already successful […]
40% of UK consumers plan to visit shopping centres less often post-COVID-19
Seen as prime destinations before COVID-19 hit, flagship shopping centres will take a long time to attract the same number of consumers back with many shunning the locations to avoid potentially crowded areas and unnecessary travel, says GlobalData, a leading data and analytics company. Sofie Willmott, Lead Analyst at GlobalData, comments: “Supermalls and flagship shopping […]
Retail sector witnessed 11.8% decline in deal activity during the week ended June 14
The number of deals announced in the global retail sector declined by 11.8% during the week ended June 14, 2020, compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The retail sector is among the worst hit due to COVID-19 and has been witnessing inconsistent deal activity […]
New deferrals show that Airbus is as exposed as Boeing to air travel crisis
Following news that Iberia has rescheduled orders of A320neo and A350; Nicolas Jouan, Aerospace and Defense Analyst at GlobalData, a leading data and analytics company, offers his view on the situation: “More deferral will be hitting Airbus’ order book after Spanish airline Ibera decided to postpone deliveries of A320neo and A350. It is a blow […]
An estimated 340 million people, 15% of 9MM population, face risk of severe COVID-19
Following the publication of a new study in The Lancet Global Health journal, examining the number of people with underlying health conditions that place them at risk of COVID-19; Katie Wrenn, Epidemiologist at GlobalData, a leading data and analytics company, offers her view on the current challenges facing the nine major markets (9MM*): “Being able […]
Royal Philips obstetrics monitoring product part of shifting landscape to remote monitoring technologies
Following the recent news that Royal Philips has launched its Avalon CL Fetal and Maternal Pod and Patch obstetrics monitoring solution for high-risk expectant mothers; Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “The lockdown measures in place across the globe have created the perfect scenario for […]
Taltz’s Nr-axSpA approval not enough to beat Cosentyx in axSpA
Despite receiving Food and Drug Administration (FDA) approval for the treatment of non-radiographic axial spondyloarthritis (nr-axSpA) before Novartis’s Cosentyx (secukinumab), Eli Lilly’s Taltz (ixekizumab) will not overthrow Cosentyx as the premiere anti-interleukin (IL) 17 biologic in the axSpA space. Taltz is forecast to achieve 2028 sales of $239m across the seven major markets (7MM*), whereas […]
London-listed oil and gas independents’ hedging strategies will help navigate 2020 turmoil
London-listed independent oil and gas companies such as Tullow Oil, Cairn Energy, Premier Oil, EnQuest and Genel Energy will continue to face hurdles in sourcing adequate financing for new developments and exploration activity as weak oil and gas prices dent their upstream businesses, according to GlobalData, a leading data and analytics company. Dwindling returns for […]
Mortgage market to see short-term hit as consumer spending plummets
Severe economic disruption caused by COVID-19 will see a short-term hit for the UK mortgage market, but payments holidays should keep it afloat and see growth from 2021, says GlobalData, a leading data and analytics company. GlobalData retail banking analyst, Resham Karira, commented: “GlobalData expects the UK’s GDP to decline in 2020 due to severe […]